SCHEMBL4854549

SCHEMBL4854549

CCCCCN1C(=O)C(c2ccc3c(c2)OCO3)(C(C)CC(=O)O)c2ccccc21

nearest known ligand 0.67

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 20/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL281669 0.89 SCN9A (0.69) SCN9A
SCHEMBL282028 0.82 SCN9A (0.80) SCN9A
SCHEMBL4854542 0.81 SCN9A (0.75) SCN9A
SCHEMBL281934 0.81 SCN9A (0.78) SCN9A
SCHEMBL281707 0.81 SCN9A (1.00) SCN9A
SCHEMBL4597622 0.80 SCN9A (1.00) SCN9A
SCHEMBL4597116 0.80 SCN9A (1.00) SCN9A
SCHEMBL4597294 0.79 SCN9A (1.00) SCN9A
SCHEMBL4596902 0.78 SCN9A (0.79) SCN9A
SCHEMBL5430583 0.77 SCN9A (0.78) SCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008046083-A2 USE OF OXINDOLE COMPOUNDS AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC. (CA) 2008-04-17 WO disclosed